Specialize, partner or perish: embrace foundry evolution for BioMEMS

Written by Jessica Gomez for SemiconductorDigest – The BioMEMS market is becoming increasingly diverse, encompassing gas and pressure sensors, ultrasound, specialized biomedical sensors, and other types of MEMS and microfluidic chips used for drug delivery and analytical applications.

The BioMEMS market is also growing steadily: Research firm Yole Développement predicts that BioMEMS will grow at 14.9% CAGR from 2017-2023, reaching US$6.9B by 2023.  As a high-value market, BioMEMS is worth pursuing as long as you can manage the complexities of manufacturing, including a sometimes-fragmented supply chain. Fortunately, the MEMS manufacturing ecosystem is evolving to accommodate the needs of companies that are in the process of commercializing BioMEMS-enabled products. Understanding the ecosystem’s shifting dynamics will help BioMEMS to flourish in this promising while often-challenging market segment.

Unique Product, Unique Process

In the world of semiconductor manufacturing, it is routine for a fab to manufacture hundreds of different device designs using just a handful of process nodes. Semiconductor foundries share their design rules with customers, who then develop the mask set accordingly, literally adapting their designs to fit the rules for manufacturing on one of the foundries’ process nodes. In stark contrast, most MEMS devices cannot conform to the level of standardized manufacturing processes that work so well for semiconductors. Rather, MEMS challenges us to develop individualized processes for each device. It’s one product, one process… Full article

Source: https://www.semiconductor-digest.com

Related presentations

Liked this post?

Share it on your social networks